Surgery for Relapsed Ovarian Cancer in Precision

Clinical trial NCT06602063 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06602063
Sponsor: Shanghai Gynecologic Oncology Group
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma

Start date: 2025-07-01
Primary completion: 2030-06-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.